Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.

Source:http://linkedlifedata.com/resource/pubmed/id/21487000

Proc. Natl. Acad. Sci. U.S.A. 2011 Apr 26 108 17 7004-9

Download in:

View as

Triples

General Info

PMID
21487000